Diabetic Foot Files

Rewind the Journey: The Preventability Index in Diabetic Limb Salvage

19 min · I går
episode Rewind the Journey: The Preventability Index in Diabetic Limb Salvage cover

Beskrivelse

Dr. G explores the "Preventability Index," a framework for replaying a patients timeline to identify missed opportunities that could have prevented a diabetic foot ulcer or amputation. He explains the five domains of the index—structural deformity, skin integrity, infection burden, vascular reserve, and time to intervene—each scored 010; higher totals indicate greater preventability. The episode emphasizes prevention through early detection, foot exams during routine visits, patient education, timely vascular and infection evaluation, and offloading. Dr. G stresses that the index is not for blame but for quality improvement and patient advocacy to reduce avoidable limb loss.

Kommentarer

0

Vær den første til å kommentere

Registrer deg nå og bli medlem av Diabetic Foot Files sitt community!

Prøv gratis

Prøv gratis i 14 dager

99 kr / Måned etter prøveperioden. · Avslutt når som helst.

  • Eksklusive podkaster
  • 20 timer lydbøker i måneden
  • Gratis podkaster

Alle episoder

330 Episoder

episode Forgotten Infection Friday — Nocardia: The Weakly Acid‑Fast Impostor cover

Forgotten Infection Friday — Nocardia: The Weakly Acid‑Fast Impostor

A 62-year-old man with poorly controlled diabetes presented with weeks of cough, weight loss, night sweats, and cavitary lung lesions initially suspected to be tuberculosis or malignancy. Sputum TB tests were negative and symptoms progressed. Bronchoscopic lung biopsy showed branching gram‑positive filaments that were weakly acid‑fast, consistent with Nocardia species. Nocardia commonly infects immunocompromised hosts, can disseminate to the brain, and is often mistaken for TB, fungal infection, or cancer. Diagnosis relies on modified acid‑fast stain, prolonged cultures, or molecular testing. Treatment requires prolonged antibiotic therapy (commonly TMP‑SMX), sometimes IV agents for severe disease, and early recognition in diabetic or immunosuppressed patients is critical to prevent dissemination.

26. juni 202624 min